Clinical Trials · NCT00170742

Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.

Name: Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

TerminatedPhase 3Octreotide

Phase: Phase 3
Recruitment status: Terminated
Sponsor: Novartis
Enrollment: 17
Start date: Dec 2003
Locations: 1 site, Switzerland
Primary endpoint: regression of neovascularization.

View Octreotide compound reference